ArticleClinical pharmacology and therapeutics2023

Physician Perspectives on the Food and Drug Administration's Decision to Grant Accelerated Approval to Aducanumab for Alzheimer's Disease.

Sanket S Dhruva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.